脆性位点抑癌基因FHIT与成年型颗粒细胞瘤的相关性
参考文献9
-
1Ohta M,Inoue H,Cotticelli MG,et al.The FHIT gene,spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint,is abnormal in digestive tract cancers.Cell,1996,84:587-597.
-
2Druck T,Hadaczek P,Fu TB,et al.Structure and expression of the human FHIT gene in normal and tumor cells.Cancer Res,1997,57:504-512.
-
3Hao XP,Willis JE,Pretlow TG,et al.Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.Cancer Res,2000,60 (1):18-21.
-
4裴红,周宝琴,魏敏.24例卵巢颗粒细胞瘤的临床分析[J].医学研究生学报,2005,18(1):45-46. 被引量：3
-
5Paradee W,Mullins C,He Z,et al.Precise localization of aphidicolin-induced breakpoints on the short arm of human chromosome 3.Genomics,1995,27:358-361.
-
6Ishii H,Dumon KR,Vecchione A,et al.Effect of adenoviral transduction of the fragile histidine triad gene in to esophageal cancer cells.Cancer Res,2001,61(4):1578-1584.
-
7吴裕中,石一复,陈晓端,朱雪琼.脆性组胺酸三聚体蛋白在上皮性卵巢肿瘤中的表达[J].现代妇产科进展,2003,12(6):404-406. 被引量：4
-
8Yura Y,Mandai M,Konishi I,et al.Loss of FHIT protein expression in high-grade and advanced stage endometrial cancinomas.Anticancer Res,2003,23(3):2837-2843.
-
9Opalka B,Dickopp A,Kirch HC.Apoptotic genes in cancer therapy.Cells Tissues Organs,2002,172(2):126-132.
二级参考文献14
-
1[1]Buttitta F, Marchetti A, Radi O, et al. Evaluation of FHIT gene alterations in ovarian cancer[ J]. Br J Cancer, 1998,77:1048-1051
-
2[2]Launonen V,Mannermaa A, Stenback F, et al. Loss of heterozygosity at chromosomes 3,6,8, 11,16, and 17 in ovarian cancer: correlation to clinicopathological variables[ J]. Cancer Genet Cytogenet,2000,122:49-54
-
3[3]Zhang GL, Xu KL. Loss of heterozygosity at chromosomes 3 in epithelial ovarian cancer in China[J].Inter J Gynecol Cancer, 2002,12:198-201
-
4[4]Ohta M,Inoue H, Cotticelli MG,et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinomaassociated t(3:8) breakpoint, is a abnormal in digestive tract cancers[J]. Cell, 1996,84:587-597
-
5[5]Mandai M, Konishi I, Kuroda H, et al. Expression of abnormal transcripts of the FHIT(fragile histidine triad) gene in ovarian cancinoma [ J ]. Eur J Cancer, 1998,34: 745- 749
-
6[6]Ozaki K, Enomoto T, Yoshino K, et al. Impaired FH-IT expression characterizes serous ovarian carcinoma[ J]. Br J Cancer,2001,85:247-254
-
7[7]Campiglio M, Pekarsky Y, Menard S, et al. FHIT loss of function in human primary breast cancer correlates with advanced stage of disease[J]. Cancer Res, 1999,59:3866-3869
-
8[8]Hao XP, Willis JE, Pretlow TG, et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions[ J]. Cancer Res,2000,60:18-21
-
9[9]Chaudhuri AR, Khan IA, Prasad V, et al. The tumor suppressor protein FHIT. A novel interaction with tubulin[J].J Biol Chem, 1999,274: 24378-24382
-
10Saul.PB. Sex cord stromal tumors[J].Clin Obstet Gynecol, 1985,28(4):839-845.
共引文献5
-
1高国兰,聂春莲,高玟,邹学森.脆性组氨酸三联体和Ki67蛋白在卵巢上皮性肿瘤组织中的表达及其临床意义[J].中华肿瘤防治杂志,2006,13(9):669-672. 被引量：2
-
2李冬洁（综述,石群立（审校）,黄文斌（审校）.卵巢恶性小圆细胞肿瘤的诊断和鉴别诊断[J].医学研究生学报,2007,20(12):1314-1317. 被引量：7
-
3杨敏,陶晨,刘霞,孟元光.卵巢颗粒细胞瘤25例临床分析[J].军医进修学院学报,2010,31(11):1077-1078.
-
4辛颖,付强,孙雷.卵巢肿瘤中FHIT和survivin的表达及临床意义[J].实用医学杂志,2012,28(8):1280-1282. 被引量：1
-
5孙丽,杨毓琴,高毅.FHIT基因在人卵巢上皮性癌组织中表达的研究现状[J].当代医学,2012,18(32):14-15.
-
1陈强强,薛菊香,姚汉武.hTERT、c-myc和Ki-67在成年型卵巢颗粒细胞瘤中的表达及其意义[J].中国医疗前沿,2010,5(23):45-46.
-
2李学勤.成年型慢性粒细胞白血病少见类型急性变二例[J].中华儿科杂志,1991,29(2):111-112.
-
3顾海风,李咏雪.成年型卵巢颗粒细胞瘤56例临床分析[J].按摩与康复医学,2016,0(22):39-40.
-
4雷艳明.成年型卵巢颗粒细胞瘤临床病理分析[J].中国实用医药,2009,4(26):104-105.
-
5付伟金,米华,刘德云,颜海标,黄伟华,莫曾南.成年型睾丸颗粒细胞瘤1例报告并文献复习[J].中国男科学杂志,2013,27(7):63-64.
-
6胡丽娜,姚汉武.PTEN和Ki-67在成年型卵巢颗粒细胞瘤中的表达及意义[J].山西医科大学学报,2010,41(2):130-132. 被引量：2
-
7王建达,张向宁,钱程,吴超.抑癌基因FHIT蛋白在大肠癌组织中的表达及临床意义[J].医学临床研究,2012,29(7):1345-1346.
-
8胡璇,胡双九.FHIT和p73在子宫内膜癌中的表达及相关性研究进展[J].中国优生与遗传杂志,2008,16(4):115-117. 被引量：1
-
9齐明,陈国林,全宝库.抑癌基因FHIT和PTEN在肝细胞癌中的表达及其意义[J].中国医药导报,2010,7(13):8-11. 被引量：1
-
10庞国莲,魏万里,张丽娟,陈芸.脆性组氨酸三联体与肺癌的临床病理学研究[J].现代肿瘤医学,2009,17(8):1483-1485.
